MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer

Cancer Discovery

Volumn 2, Issue 12, 2012, Pages 1100-1108

  Mitra, Anirban K ^a   Zillhardt, Marion ^a   Hua, Youjia ^b   Tiwari, Payal ^a   Murmann, Andrea E ^b   Peter, Marcus E ^b   Lengyel, Ernst ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYCLOOCTENYLMETHYL) 4 (2,7 DICHLOROXANTHEN 9 YLCARBOXAMIDO) 1 ETHYLPIPERIDINIUM IODIDE; ANTINEOPLASTIC AGENT; CCL5 ANTIBODY; CHEMOKINE RECEPTOR CCR ANTAGONIST; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MICRORNA; MICRORNA 155; MICRORNA 214; MICRORNA 31; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; CELL INVASION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; OVARIAN NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

EID: 84871528926     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-12-0206     Document Type: Article

References (24)

1. Hanahan D, Coussens LM. Accessories to the crime: Functions of cell recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-22.
2. Barkan D, Green JE, Chambers AF. Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 2010; 46: 1181-8.
3. Schauer IG, Sood AK, Mok S, Liu J. Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia 2011; 13: 393-405.
4. Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis throught elevated SDF-1/CXCL 12 secretion. Cell 2005; 121: 335-48.
5. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
6. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: Key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27: 5959-74.
7. Ambasudhan R, Talantova M, Coleman R, Yuam X, Zhu S, Lipton SA, et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 2011; 9: 113-8.
8. Kim KS. Converting human skin cells to neurons: A new tool to study and treat brain disorders? Cell Stem Cell 2011; 9: 179-81.
9. Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Sacca M, Memeo L, et al. Control of tumor and microenvironment crosstalk by miR-15a and miR-16 in prostate cancer. Oncogene 2011; 30: 4231-42.
10. Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, et al. mir-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep 2012; 1: 141-54.
11. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol 2010; 177: 1053-64.
12. Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Trimmer C, et al. The autophagic tumor stroma model of cancer or "battery-operated tumor growth" a simple solution to the autophagy paradox. Cell Cycle 2010; 9: 4297-306.
13. Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, et al. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 2010; 9: 4387-610.
14. Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics 2009; 2: 71.
15. Tsukishiro S, Suzumori NNH, Aarakawa A, Suzumori K. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder. Gynecol Oncol 2006; 102: 542-5.
16. Haniffa MA, Wang XN, Holtick U, Rae M, Isaacs JD, Dickinson AM, et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007; 179: 1595-604.
17. Karnoub A, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-63.
18. Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL, et al. Breastcancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 2007; 357: 2543-51.
19. Tuhkanen H, Anttila M, Kosma VM, Heinonen S, Juhola M, Helisalmi S, et al. Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas. Int J Cancer 2006; 119: 1345-53.
20. Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008; 40: 650-5.
21. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005; 37: 899-905.
22. Proia DA, Kuperwasser C. Reconstruction of human mammary tissues in a mouse model. Nat Protoc 2006; 1: 206-14.
23. Kenny HA, Krausz T, Yamada SD, Lengyel E. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells. Int J Cancer 2007; 121: 1463-72.
24. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumorpromoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010; 17: 135-47.